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Abstract The intracellular proteolytic processing of HIV 
envelope glycoprotein gpl60 into gpl20/gp41 is an essential step 
for virus infectivity. Several convertases, belonging to the pro-
protein convertase family, have been proposed as candidate 
gpl60 processing enzymes. Here we demonstrate using RT-PCR 
that resting human T4 lymphocytes weakly express PC7, furin, 
and PC5 mRNA whereas lymphocytes activated under conditions 
favoring HIV replication express 5-10-fold higher levels of furin 
and PC7. In this report, we examined the capability of the newly 
cloned convertase PC7 to cleave gpl60 into gpl20/gp41 and 
compared it to furin. This was carried out in a cell-based assay 
whereby both gpl60 and the cognate convertase were co-
expressed in the constitutively secreting BSC40 cells and in the 
regulated AtT20 cells, as well as using two in vitro assays which 
examined the cleavage of gpl60 or of a synthetic peptide 
spanning the cleavage site. The data demonstrate that PC7 can 
cleave specifically and in a cell-type specific manner gpl60 into 
gpl20/gp41, suggesting that both furin and PC7 are so far the 
major PC-like candidate gpl60 convertase in T4 lymphocytes. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The lymphotropic HIV enveloped virus infects target cells 
by a multistep process, involving both fixation to the C D 4 + 
receptor and fusion between the viral envelope and host cell 
membrane. Fusion is mediated by the mature envelope glyco-
protein gpl20/gp41, synthesized as an inactive precursor, 
gp l60 . During its transit through the host cell constitutive 
secretory pathway, gpl60 is cleaved at the conserved RE-
K R ¿ A V sequence, generating the gpl20/gp41 complex 
present at the surface of the infectious viruses [1]. 
Recently, seven members of a novel family of kexin/subti-
lisin-like serine proteinases known as pro-protein convertases 
(PCs) have been molecularly characterized. These include the 
widely expressed furin and PC7, the endocrine and non-endo-
crine enzymes PC5 and PACE4, the neural and endocrine 
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Abbreviations: W , vaccinia virus; PC, precursor convertase; RT-
PCR, reverse transcriptase polymerase chain reaction; HIV, human 
immunodeficiency virus; gp, glycoprotein; WT, wild-type; PBS, 
phosphate-buffered saline; BSA, bovine serum albumin; F ACS, 
fluorescence-activated cell sorting 
convertases PCI and PC2 and the germ cell-specific PC4 
(for reviews and updates see [2-5]). Because of their general 
preference for cleavage post specific single or pairs of basic 
residues, some of these enzymes have been proposed to par-
ticipate in the processing of gpl60. Thus, furin was first 
shown to cleave gpl60 intracellularly into gpl20/gp41 by Hal-
lenberger et al. [6]. Cellular coexpression studies [7] and in 
vitro assays [8,9] further demonstrated that furin, PACE4, 
PC5-A and its isoform PC5-B, and PCI may process gpl60. 
Since the main HIV host cells in vivo are the CD4+ lympho-
cytes, derived cell lines were shown to express mainly m R N A 
coding for furin, PC7 [9] and PC5 [9,10], suggesting that these 
convertases may be the best physiological candidates for the 
proteolytic cleavage of gpl60 in T4 lymphocytes. However, it 
is important to perform such experiments in primary cells and 
not just in cell lines. Furthermore, since HIV replication 
mostly occurs in activated T4 lymphocytes [11], it also be-
comes imperative to define the convertases expressed in both 
resting and activated human immune cells. 
Using semi-quantitative RT-PCR, in this work, we defined 
the main candidate gpl60 convertase m R N A s expressed in 
resting and activated human T4 lymphocytes obtained from 
healthy donors. The detection of PC7-specific transcripts in 
these cells led us to evaluate by ex vivo and in vitro assays the 
putative involvement of PC7 in the proteolytic cleavage of 
gpl60. 
2. Materials and methods 
2.1. Isolation of T4 lymphocytes by negative selection and RT-PCR 
assays 
Human lymphocytes were isolated from peripheral blood mononu-
clear cells (PBMC) prepared on a Ficoll-Paque (Pharmacia no. 
17084003) discontinuous gradient by 40 min centrifugation at 1800 
rpm and 20°C. Lymphocytes were collected at the Ficoll interface and 
washed 3 times in 1% (w:v) bovine serum albumin in phosphate-buf-
fered saline (PBS-BSA), in order to remove the platelets. The PBMC 
resuspended at a density of 5X106 cells/ml in PBS-1% BSA were 
incubated for 1 h at 37°C on plastic dishes in order to eliminate 
adherent monocytes. The floating cells were centrifuged for 10 min 
at 1400 rpm, resuspended at 20X106 cells/ml in PBS-1% BSA and 
incubated for 45 min at 4°C with a cocktail of antibodies at 20 ug/ml 
(OKT8, 3C10, NN3, LM-2, LYM-1, and IV.3). After two washes in 
PBS-1% BSA, the cells were incubated for two rounds for 45 min at 
4°C on a plastic petri dish precoated with anti-mouse IgG at 20 ug/ml 
(Sigma M8642) in 0.05 M Tris-HCl pH 9. The cells collected in the 
supernatant were assessed by fluorescence-activated cell sorting 
(FACS) analysis and shown to contain at last 96% of CD4+ cells in 
each experiment. The cells were then cultured for 4 days in an RPMI 
medium containing synthetic serum (ICN Flow), 1% bovine serum 
albumin, with or without [2 ug/ml phytohaemagglutinin (PHA), and 
15 units/ml of interleukin-2 IL-2] (Gibco). The RT-PCR reactions 
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were performed after TRIzol RNA extraction with the human PC-
specific oligonucleotides, as described in [9]. The antibodies used were 
purified from the supernatant of hybridoma cultures using a T-gel 
column (Pierce). The hybridomas (ATCC) used produce mouse anti-
body reactive to CD4 receptors (OKT4; no. CRL-8002), CD8 recep-
tors (OKT8; no. CRL-8014), Fc receptors (cdl4) (3C10; no. TIB-
228), glycophorin A (NN3; no. HB 8474), mac-1 receptor (cdllb) 
(LM/2; no. HB-204), B cells (LYM-1; no. HB-8612), natural killer 
and killer cells (HNK-1 ; no. TIB-200) and IgG Fc receptor II (cdw32) 
(IV.3; a gift from Dr. R. Sekaly, IRCM). 
2.2. Vaccinia virus recombinants and cellular expression studies 
The recombinant vaccinia virus (VV) encoding gpl60 and 
W:BTMD-hfurin were respectively gifts from Drs. B. Moss (NIH), 
and G. Thomas (Vollum Institute, Oregon). The purified vaccinia 
viruses recombinant expressing full length hfurin [12] and rat PC7 
and its truncated form before its transmembrane domain (BTMD-
rPC7) (S. Munzer and N.G. Seidah, submitted) were obtained as in 
[12], Co-expression studies using VV:gpl60 and either VV:hfurin or 
W:rPC7, the 4 h [36S]methionine labeling of BSC40 and AtT20 cells 
and the immunoprecipitation of gpl60 and its processed products 
were performed as in [7]. 
2.3. Purification of convertases, fluorometric and in vitro assays 
Secreted BTMD-hfurin and BTMD-rPC7 were purified from the 
media of W infected GH4Ci cells using a previously described puri-
fication procedure [9]. Enzymatic activities were monitored using the 
fluorogenic substrate pERTKR-MCA [200 uM] in 1 mM CaCl2, 50 
mM Tris-acetate, pH 6.5 for BTMD-rPC7 and pH 7 for BTMD-
hfurin as described [8]. In vitro endoproteolytic cleavage of gpl60 
and of the synthetic peptide spanning the gpl20-gp41 junction was 
performed as in [9]. 
3. Results 
3.1. Expression of convertases in freshly isolated human 
T4 lymphocytes 
T4 lymphocytes, the major target of HIV, were purified by 
a negative panning technique from the blood of healthy do-
nors. FACS analysis demonstrated that at least 96% of the 
isolated cells are CD4+ (not shown). Since HIV viral replica-
tion occurs mainly in activated T4 lymphocytes [11], using 
semi-quantitative RT-PCR we compared the expression of 
the PCs in both resting and T4 lymphocytes activated with 
a mixture of PHA and IL-2. Fig. 1 shows the relative mRNA 
levels of PCs in T4 lymphocytes, at days 0 and 4 with or 
without activation. The results were normalized with respect 
to the levels of mRNA expression of the ribosomal house-
keeping protein L27, as described [9]. These data, averaged 
over duplicate results obtained from T4 cell preparations of 
3 healthy individuals, demonstrate that PC7, PC5 and furin 
are the three main convertases expressed in resting T4 Lym-
phocytes. In contrast, no PCI or PC2 mRNA transcripts were 
found in the isolated cells and only insignificant levels of 
PACE4 mRNA were detected in one of the 3 independent 
preparations. Furthermore, we demonstrated that culturing 
T4 lymphocytes for 4 days, especially in the presence of 
PHA/IL-2, leads to a significant increase in the level of ex-
pression of furin and PC7, but not of PC5 (Fig. 1). These data 
suggest that furin [6-9] and the newly discovered PC7 [5] 
represent the major PC-like candidates for the processing of 
gpl60 in activated T4 lymphocytes. 
3.2. Comparative processing of gpl60 by furin and PC7 in 
BSC40 and AtT20 cells 
Since we previously reported that furin cleaves gpl60 to 
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Fig. 1. Identification of precursor convertases mRNA in resting and 
4-day activated human T4 lymphocytes from healthy donors. Hu-
man T4 lymphocytes were isolated (day 0) and cultured for 4 days 
in the absence or presence of a mixture of PHA and IL-2. Each 
RT-PCR amplification (28 cycles) was performed using convertase 
specific primers together with two others specific for the control ri-
bosomal L27 protein, as described [9]. The bar graphs represent the 
quantitation of the relative amount of each convertase normalized 
to the control L27. The data are an average (± standard deviation) 
of RT-PCR experiments performed on RNA isolated from duplicate 
values obtained from 3 different individual donors. 
secreting, e.g. BSC40 cells and in regulated cells containing 
secretory granules, e.g. AtT20 cells [7], we compared the proc-
essing of gpl60 by either furin or PC7 in both cell types. 
Thus, following overnight infections with either VV:gpl60 
and either VV:WT, VV:rPC7 or VV:hfurin, BSC40 (Fig. 
2A) and AtT20 (Fig. 2B) cells were pulse-labeled with 
[35S]methionine for 4 h. Cell extracts and media were analyzed 
by SDS-PAGE of the immunoprecipitated proteins using a 
gpl60 antiserum derived from a pool of AIDS patients [7]. 
In the control experiment (VV:WT), we note the formation of 
some gpl20 resulting from endogenous BSC40 or AtT20 con-
vertase activities. Note that in AtT20 cells, the gpl50 protein 
represents the initial ER-localized precursor, whereas gpl60 is 
the convertase-susceptible form which reached the trans Golgi 
network [7]. In contrast, in BSC40 cells both forms comigrate 
using these SDS-PAGE separation conditions [7]. Differently 
from furin, the degree of increase in the level of gpl20 se-
creted into the medium suggests that processing of gpl60 
into gpl20/gp41 by PC7 is much more efficient in BSC40 cells 
as compared to AtT20 cells (Fig. 2). On the other hand, the 
generation of gp77/gp53 from gpl20 [7,8] is best accomplished 
by furin in either cell type. Thus, we conclude that furin and 
PC7 can process gpl60 into gpl20, but that PC7 can best 
generate the latter product in constitutively secreting cells. 
In addition, further processing of gpl20 into gp77/gp53 is 
mainly performed by furin. Interestingly, in AtT20 cells and 
to a lesser extent in BSC40 cells, rPC7 (89 kDa) co-immuno-
precipitated with the HIV envelope products in cell extracts 
(Fig. 2). The same band was also detected with a PC7-specific 
antibody (not shown). Although we do not know the exact 
mechanism for this phenomenon, it is interesting to note that 
gpl20 was recently shown to bind fibronectin [13], suggesting 
that gpl20 can interact with proteins other than the CD4+ 
receptor or its co-receptor fusin [14]. 
3.3. In vitro digestion of gp!60 by soluble rPC7 and hfurin 
In order to compare the efficiency of gpl60 processing by 
70 E. Decroly et al.lFEBS Letters 405 (1997) 68-72 
B 
Fig. 2. Cellular processing of gpl60 by furin and PC7. (A) BSC40 and (B) AtT20 cells were co-infected with VV:gpl60 and either W:WT, 
W:hfurin or W:rPC7 at a multiplicity of 2 plaque forming units/cell (pfu/cell). Following overnight culture, the cells were washed and then 
pulse-labeled for 4 h with [35S]methionine, as described [7]. Cell extracts and media were submitted to immunoprecipitation with a gpl60 antise-
rum, analyzed by SDS-PAGE (8% T, 2.7% C), and fluorographed as described [7]. 
either hfurin or rPC7, we tested the in vitro ability of using a recombinant vaccinia virus, and partially purified on 
these enzymes to cleave gpl60 into gpl20 and gp41. a lentil-lectin column [8]. The source of soluble hfurin 
[35S]Methionine-labeled gpl60 was expressed in CV-1 cells (BTMD-hfurin) and rPC7 (BTMD-rPC7) was the 50-fold con-
Fig. 3. Comparative in vitro cleavage of gpl60 by BTMD-hfurin- and BTMD-rPC7. [35S]Methionine-labeled gpl60 was digested in vitro by in-
creasing concentrations of BTMD-rPC7 and BTMD-hfurin. The digestions were performed in 100 \ú of 1 mM CaCl2, 1% Triton X-100, 50 
mM Tris acetate buffer pH 6.5 or 7, respectively. In each assay, the corresponding enzyme activity on the fluorogenic pERTKR-MCA peptide 
was reported in arbitrary units, 1 unit corresponding to 3.3 nmol of released AMC per 16 h. The products were separated by SDS-PAGE (7% 
T, 2.4% C) and the dried gel fluorographed. 
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Fig. 4. Cleavage of the gpl20/gp41 junctional 19 aa peptide by 
BTMD-hfurin and BTMD-rPC7. The 19 aa model peptide was in-
cubated for 1 h at 37°C with increasing activities of either BTMD-
hfurin or BTMD-rPC7, based on the level of AMC released from 
pERTKR-MCA. The generated peptides were separated on a Vydak 
C18 RP-HPLC column, their elution monitored at 214 nm, and the 
area under each peptide peak was integrated. The % cleavage is de-
fined as the area under each product peak divided by the total 
areas. 
centrate obtained from the media of GH4C1 cells infected 
with their VV: recombinants. In vitro digestions were per-
formed using increasing concentrations of enzymes with 
15000 cpm of [35S]methionine-labeled gpl60. Fig. 3 demon-
strates that using two comparable levels of enzymatic activity, 
measured in parallel with the fluorogenic pERTKR-AMC 
peptide, the soluble BTMD-hfurin is much more efficient in 
cleaving gpl60 into gpl20 and gp41 as compared to BTMD-
rPC7, which barely cleaves gpl60 in vitro. However, in BSC40 
cells rPC7 cleaves gpl60 much better that BTMD-rPC7 (not 
shown), suggesting that the membrane-anchored rPC7 (S. 
Munzer and N.G. Seidah, submitted) is more active on 
gpl60 than the soluble BTMD form. 
3.4. In vitro digestion of a model 19 amino acid peptide 
spanning the gpl20lgp41 cleavage site 
Since no cleavage kinetics could be derived from the gpl60 
processing experiment, we chose to analyze the specificity 
and kinetics of cleavage of the gpl20/gp41 site by studying 
the processing of a model 19 amino acid peptide 
(PTKAKRRVVQREKR5i2¿AVGIG) encompassing the se-
quence at the REKR-AV junction of gpl20 and gp41. This 
model peptide was digested by either BTMD-hfurin and 
BTMD-rPC7 and the cleavage products were separated by 
RP-HPLC and characterized by amino acid analysis, as de-
scribed [9]. Both furin and PC7 yield two main products 
(PTKAKRRVVQREKR and AVGIG, not shown), resulting 
from the cleavage of this peptide at the same position as the 
physiological gpl60 in vivo cleavage site. Fig. 4 depicts the 
calculated percent of peptide cleaved by increasing activities 
of furin and PC7, measured with the substrate pERTKR-
MCA. These data suggest that the 19 amino acid peptide is 
better cleaved by BTMD-hfurin than by BTMD-rPC7. In the 
absence of a specific active site titrant for the PCs, we per-
formed kinetic measurements allowing us to estimate the Km 
of this reaction for each enzyme. The data (not shown) re-
vealed that the Km deduced from the BTMD-rPC7 processing 
is about 45 ± 8 u,M, which is quite similar to that estimated for 
BTMD-hfurin (16 ±7 u,M) [9]. Therefore, these data suggest 
that the difference in the ability of furin and PC7 to process 
gpl60 in vitro may be due to a higher turnover rate (/ccat 
value) for soluble furin as compared to soluble PC7. 
4. Discussion 
The results presented in this work define the nature of the 
major convertases expressed in resting human T4 lymphocytes 
as furin, PC7 and PC5 and, in activated T4 lymphocytes as 
furin and PC7 (Fig. 1). These data resemble those derived 
from immortalized CD4+ cell lines, such as Jurkat, CEM-T4 
and SupT-1 [9]. In agreement with previous data demonstrat-
ing that phorbol esters upregulate the level of furin in H9 cells 
[8], our results showed that activation of primary human T4 
lymphocytes with a mixture of PHA and IL-2, known to 
enhance HIV viral replication [11], increases the level of furin 
and PC7 with little effect on PC5 (Fig. 1). However, we also 
note that just culturing T4 lymphocytes for 4 days without 
added PHA/IL-2 results in an upregulation of the level of PC7 
mRNA but not that of furin (Fig. 1). These results also sug-
gest that the mRNA level of PC7 is more sensitive than that 
of furin to effectors already present in the culture medium. It 
will be of interest to define the endogenous T4-cell substrates 
for these enzymes which may be co-regulated by the same 
activation and which when cleaved could perform critical 
functions in the immune system. 
In view of the fact that the constitutively secreting T4 lym-
phocytes are the main targets of HIV infection, our analysis 
of PC-expression results suggest that furin and PC7 are the 
main PC-like candidate gpl60 convertases. To test this hy-
pothesis directly, we co-expressed vaccinia virus recombinants 
coding for gpl60 and each of the above two enzymes. In an 
earlier study, we showed that furin processes gpl60 intracel-
lularly much better than PC5 [7] and, in this study, PC5 was 
demonstrated to be less expressed in activated lymphocytes 
than either furin or PC7. Thus, in the present report the ex 
vivo and in vitro gpl60 processing by furin was compared to 
that obtained with PC7. Cellular co-expression results showed 
that furin and PC7 cleaved gpl60 differently (Fig. 2). Thus, 
whereas PC7 mainly processes gpl60 into gpl20/gp41, espe-
cially in the constitutively secreting BSC40 cells, furin further 
cleaves gpl20 to gp77/gp53, as previously reported [7]. In a 
similar fashion, PC7 was also shown to cleave the PC-inhib-
itor protein ocl-PDX [8,9,15] much better in constitutive ver-
sus regulated cells (S. Benjannet et al., submitted). A possible 
explanation for the cell-type specificity observed for PC7 may 
be related to the fact that this enzyme is mostly localized in 
the Golgi apparatus in either cell types (N.G. Seidah and M. 
Marcinkiewicz, unpublished data), whereas furin and gpl60 
may transit from the immature granules of AtT20 cells to the 
cell surface and into endosomes [16,17]. 
In order to define the cleavage kinetics of gpl60 into gpl20/ 
gp41 by either enzyme, we compared the ability of soluble 
BTMD-hfurin and BTMD-rPC7 to cleave in vitro 
[35S]methionine-labeled gpl60 (Fig. 3). This experiment dem-
onstrated that for equal enzymatic activity (measured on the 
pERTKR-MCA peptide) BTMD-hfurin cleaves gpl60 into 
gpl20/gp41 much more efficiently than BTMD-rPC7. These 
in vitro results contrast with those obtained in BSC40 cells 
(Fig. 2) which demonstrated that the membrane-anchored 
72 E. Decroly et al.lFEBS Letters 405 (1997) 68-72 
PC7 (in contrast to BTMD-rPC7) is able to efficiently cleave 
gp l60 into gpl20/gp41 intracellularly. Thus, it is possible that 
membrane anchoring of either native PC7 or furin may favor 
the interaction of PC7 with the membrane-bound gpl60. Al-
ternatively, rPC7 may interact with other cellular proteins for 
maximal activity or it may activate yet another undefined 
gp l60 processing enzyme, as previously suggested [18,19]. 
Finally, in order to derive more precise kinetic values for 
this cleavage, furin and PC7 were compared in their ability to 
process a 19 aa model peptide spanning the gpl20/gp41 junc-
tion [9]. The data demonstrated that BTMD-rPC7 cleaves this 
peptide at the expected R E K R J, AV physiological site with a 
Km of 45 ± 8 u M as compared to that of BTMD-hfurin esti-
mated at 16 ± 7 uM. This difference in Km values does not, by 
itself, explain the marked efficiency of soluble furin as com-
pared to BTMD-rPC7 to cleave either gpl60 or the 19 aa 
peptide (Figs. 3 and 4). It is thus likely that the turnover 
number (fccat) of BTMD-hfurin is higher than that of 
BTMD-rPC7. However, in the absence of active site titrant, 
the answer to this question will have to await further experi-
ments. 
In conclusion, the data presented demonstrate that both 
furin and PC7 are the main candidate PC-like enzymes which 
could participate in the processing of gpl60 in T4 lympho-
cytes activated under conditions favoring HIV replication. It 
is interesting to note that a recent report suggested that a 
PACE4-activated protein with an apparent molecular mass 
of about 90-95 k D a (similar mass to PC7) was expressed in 
the furin-deficient RPE-40 cells, in which gpl60 is efficiently 
cleaved into gpl20/gp41 [16]. Since both furin and PC7 re-
quire < 100 u,M C a 2 + for activity, we found it very difficult to 
eliminate their membrane-bound activity by using chelators 
such as E D T A or E G T A at 1-2 m M concentrations (J.C. 
Munzer and N . G . Seidah, submitted). Thus, future work 
should clarify the degree of involvement in gp l60 processing 
of furin and PC7 in cell types other than the T4 lymphocytes 
and whether truly calcium-independent enzymes, distinct from 
PC-like convertases [18,19], also participate in the in vivo 
processing of gpl60 . 
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